web analytics
27.4 C
Karachi
Saturday, August 9, 2025
PSL 10
PSX
Gold Rates
Currency Exchange
HomeTagsMolnupiravir

All Stories: molnupiravir

Molnupiravir: China grants conditional approval for COVID treatment

China has granted conditional approval for the import of Merck's COVID-19 treatment Molnupiravir, China's medical products regulator said on Friday. Molnupiravir, developed by Merck which...

WHO recommends Merck’s COVID pill for high-risk patients

A World Health Organization (WHO) panel on Wednesday backed the use of molnupiravir- Merck & Co's COVID-19 antiviral pill- for high-risk patients. The expert panel...

Merck’s COVID-19 pill effective against Omicron in lab studies

Merck and partner Ridgeback Biotherapeutics said on Friday six lab studies showed that their experimental oral COVID-19 drug, molnupiravir, was active against the...

UK to begin testing Merck’s COVID pill for hospitalised patients

UK scientists will begin testing Merck and Ridgeback Biotherapeutics' antiviral pill molnupiravir as a possible treatment for patients hospitalised with COVID-19, amid the worldwide...

Mexico grants emergency use approval for Merck’s COVID-19 pill

Mexico's health regulator has granted authorization for emergency use of drugmaker Merck's COVID-19 pill Molnupiravir, President Andres Manuel Lopez Obrador said on Friday. The health...

Belgium to buy 10,000 courses each of Pfizer and Merck COVID-19 pills

Belgium will buy 10,000 courses each of the COVID-19 pills developed by Pfizer and Merck, a spokesman for the health ministry said in an...

Japan health panel approves Merck’s oral COVID-19 treatment

A Japanese health ministry panel on Friday recommended approval of the COVID-19 antiviral pill developed by Merck, part of Prime Minister Fumio Kishida's plan...

France cancels order for Merck’s COVID-19 antiviral drug

France has cancelled its order for Merck's COVID-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer's competing drug before the...

Indonesia reviewing Merck COVID-19 pill, up to 1 mln doses targeted

Indonesia is reviewing a COVID-19 experimental antiviral pill- molnupiravir- produced by Merck for domestic use, its food and drug agency (BPOM) chief said on...

Britain approves Merck’s COVID-19 pill in world first

Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill -molnupiravir- jointly developed by Merck and...

Molnupiravir: Countries rush to buy Merck experimental COVID-19 pill

Merck has signed eight deals to sell more than a total of 2 million courses of its experimental COVID-19 pill molnupiravir to governments around...

Merck signs pact to allow more companies to manufacture COVID-19 pill

Merck has signed a licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) that will allow more companies to manufacture generic versions of...

Molnupiravir: Heres’ what you need to know about Merck’s COVID-19 pill

As Merck and partner Ridgeback Biotherapeutics announced earlier this month that their pill Molnupiravir was found effective against COVID-19, they made headlines around the...

WHO says it awaits full data from Merck on COVID-19 pill molnupiravir

The World Health Organization is awaiting full clinical data on the antiviral pill made by Merck & Co to treat mild-to-moderate COVID-19 patients, a...

Merck applies for US authorization of COVID-19 pill

Merck & Co said on Monday it has applied for emergency use authorization in the United States for its oral drug to treat mild-to-moderate...

Merck and Singapore sign deal on COVID-19 antiviral pill

Pharmaceutical company Merck announced on Wednesday a supply and purchase agreement with Singapore that will ensure it access to its experimental oral COVID-19 antiviral...

Merck’s COVID-19 pill cuts risk of death, hospitalization by 50%: study

Merck's experimental oral drug for COVID-19, molnupiravir, reduced by around 50% the chance of hospitalization or death for patients at risk of severe disease,...

United States signs $1.2 bln deal for ‘COVID-19 drug’

The oral antiviral treatment, molnupiravir, aims to stop COVID-19 from progressing and can be given early in the course of the disease, similar to Tamiflu to treat influenza
-Advertisement-
 

Trending

BREAKING NEWS

MUST READ

ABOUT US

ARY NEWS brings you 24/7 Live Streaming, Headlines, Bulletins, Talk Shows, Infotainment, and much more. Watch minute-by-minute updates of current affairs and happenings from Pakistan and all around the world!

CORPORATE

ARY NETWORK

DOWNLOAD NOW!

© 2025 ARYNEWS.tv. All Rights Reserved.